Personal Mentors

Long-term support from the CareZ community

Personal Mentors are Alpha-1 patients who provide long-term support and guidance to other Alphas in need. Mentors will call patients every month (or more often if the patient desires) to check in and provide assistance with a variety of issues, including:

  • Helping to ensure patients get their Zemaira treatment
  • Arranging transportation to medical appointments
  • Offering emotional support*

How to connect with a mentor

To get in touch with a Personal Mentor, please take the following steps:

  • Download and complete an enrollment form below
  • Print your completed form
  • Fax completed form to 1-888-415-2162, or

  • Mail completed form to:

    Zemaira Alpha-1 Programs
    c/o AccessMED, Inc.
    6900 College Blvd, Suite 1000
    Overland Park, KS 66221

Sign up for mentor support

To find out more about the Personal Mentor program, contact a CareZ Case Manager at 1-888-415-2167.

* Emotional support does not constitute professional guidance or psychological or therapeutic counseling; our specialists offer experience-based, nontherapeutic advice and support in handling the difficulties of living with Alpha-1.

Important Safety Information

Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.

Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.

In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).

Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Please see full prescribing information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Do you want to continue?

No Yes